Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dinuoan vs Visanne for ovarian endometrioma
ChiCTR2200062743Phase 4Not yet recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dienogest in endometrioma (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoint: Ovarian cyst size. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
dienogest
03
Conditions
endometrioma
Beyond the preview
Go deeper on ChiCTR2200062743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062743.